If your friend or loved one has cancer, you may have searched online for products to help them manage side effects from treatment. Unfortunately, some products you find online don’t live up to the promises in their sales pitches. People should talk with their health professionals before trying new products, and ask if there are reputable studies to support the claims made about the product. Patients want to be sure a product won’t interfere with their treatment, or delay them from getting care from a medical professional who is qualified to treat cancer.
The FTC sued a business and business owner that marketed two products to cancer patients, but didn’t have the scientific evidence they needed to support claims about the products. The marketers claimed that CellAssure drink mix was clinically proven to be an effective treatment for cancer patients’ malnutrition, and Cognify dietary supplement was proven to treat “chemo brain.” In fact, there aren’t any human clinical studies that show CellAssure or Cognify treat those symptoms as advertised. Now, these marketers are prohibited from making claims that lack the necessary scientific evidence to support them.
Learn about evaluating the claims you see when you shop for health-related products. If you spot fraud — online, in a store, or on the phone — please tell the Federal Trade Commission.
The purpose of this blog and its comments section is to inform readers about Federal Trade Commission activity, and share information to help them avoid, report, and recover from fraud, scams, and bad business practices. Your thoughts, ideas, and concerns are welcome, and we encourage comments. But keep in mind, this is a moderated blog. We review all comments before they are posted, and we won’t post comments that don’t comply with our commenting policy. We expect commenters to treat each other and the blog writers with respect.
We don't edit comments to remove objectionable content, so please ensure that your comment contains none of the above. The comments posted on this blog become part of the public domain. To protect your privacy and the privacy of other people, please do not include personal information. Opinions in comments that appear in this blog belong to the individuals who expressed them. They do not belong to or represent views of the Federal Trade Commission.